SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-017739
Filing Date
2024-02-28
Accepted
2024-02-28 07:00:02
Documents
2
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0200863-6k_kamada.htm 6-K 11446
2 KAMADA TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS, AND PR ea0200863ex99-1_kamada.htm EX-99.1 7098
  Complete submission text file 0001213900-24-017739.txt   19569
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 24690111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)